SRTS Sensus: Likuiditas cepet

The price action of Sensus Healthcare, Inc. (SRTS) reflects the dynamics of an asset whose operations are based on creating AI systems for skin radiation therapy with automatic dose calibration. The current indicator stands at 4.12, which is relevant amid growing interest from private US clinics in safe outpatient cancer treatment methods. High barriers to entry are ensured by patents on radiation sources and strict FDA oversight.

The complex logistics of high-precision radiation therapy equipment require Sensus Healthcare, Inc. (SRTS) to maintain significant reserves to ensure operational reliability. The current critical liquidity ratio of 4.12 measures the company's ability to settle short-term obligations using only cash and accounts receivable while ignoring slow-moving inventory, allowing investors to assess the business's actual solvency without accounting for warehouse stock.